FindTrial
Sign In

A clinical-endoscopic-radiographic nomogram for predicting moderate-to-severe obstructive sleep apnea-hypopnea syndrome in children with adenoid hypertrophy

A clinical-endoscopic-radiographic nomogram for predicting moderate-to-severe obstructive sleep apnea-hypopnea syndrome in children with adenoid hypertrophy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128558
Enrollment
Unknown
Registered
2026-07-22
Start date
2026-07-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoid Hypertrophy, Moderate-to-severe Obstructive Sleep Apnea Hypopnea Syndrome in Children

Interventions

Non-moderate-to-severe OSA group,moderate-to-severe OSA group:None

Sponsors

Yongchuan Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Aged 3–14 years; 2. Patients admitted to our hospital for PSG examination and endoscopic/imaging examinations due to symptoms such as snoring during sleep and mouth breathing; 3. Complete clinical data available; 4. Diagnosed with adenoid hypertrophy.

Exclusion criteria

Exclusion criteria: 1. Combined with congenital maxillofacial malformations, neuromuscular diseases or inherited metabolic disorders; 2. Previous history of adenoid/tonsil surgery; 3. In the period of acute upper respiratory tract infection; 4. Severe lack of clinical data.

Design outcomes

Primary

MeasureTime frame
Moderate-to-severe obstructive sleep apnea-hypopnea syndrome;—

Countries

China

Contacts

Public ContactXia Deng

Yongchuan Hospital of Chongqing Medical University

729964634@qq.com+86 23 85381665

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026